BIOPHARMA
Biopharma are advanced therapeutics developed using biotechnology, including proteins, antibodies, and nucleic acids. We provide a complete range of tools—such as protein characterization, glycan analysis, bioassays, ADC tools, and PK/immunogenicity kits—to support biopharma development and quality control.
Protein Characterization
We provide protein characterization tools to evaluate purity, identity, and bioactivity, ensuring reliable results for biologics development.
Glycan Characterization
Our SmartEnzymes™-based glycan characterization tools enable precise, high-throughput analysis of glycosylation in biopharmaceuticals, supporting both R&D and QC.
Bioassay
Our bioassays measure the activity and potency of biotherapeutics with high sensitivity, supporting development, quality control, and regulatory compliance.
ADC
Allianz Bio offers high-quality antibodies, enzymes and kits for ADC development, enabling precise evaluation of binding, internalization, and cytotoxicity to support efficient drug development.
Therapeutic Antibodies
We provide high-quality therapeutic antibodies, along with specialized reagents that support every stage of antibody development—including target validation, functional characterization, and optimization.
PK/Immunogenecity
We offer high-performance tools such as Anti-Idiotypic antibodies and kits for PK and immunogenicity studies, enabling accurate quantification and anti-drug antibody detection for regulatory support.